他克莫司與達(dá)格列凈聯(lián)合用藥對(duì)IgA腎病患者腎功能和免疫功能的影響分析
Efectsof tacrolimus combined with dapagliflozin on renal and immune function in patientswith IgA nephropathySu Xiaoxia.Department of Nephrology,Qinzhou Second People's Hospital,Guangxi 5350o,China
【Abstract】ObjectiveTo explore the effcts of the combination of tacrolimus and dapagliflozinon renal and immune function in patients with IgA nephropathy.MethodsA total of 70IgA nephropathy patients diagnosedand treatedinourhospital wereincludedinthisstudyfrom January 2O2O to October2O23andwere randomly divided intotwo groups.All patientswere givenroutine treatmentssuch asdiuresis,electrolyte correction,blood pressurereduction,anddietary guidance,aswell asoral administrationof prednisone acetate tablets.At the same time,the control group (35cases)was treated with dapagliflozin,while the observationgroup (35cases)was treated withacombinationof tacrolimusanddapagliflozin.Theclinical eficacy,renal function indicators (blood creatinine,urea nitrogen,24-hour urine protein level),immune function indicators (CD3 β+ ,CD 4+ , CD8+,CD4+/CD8*),and adverse reactions were compared between the two groups.ResultsThe overall fficacy rate of the observation group surpassed the control group significantly ( P <0.05).Following the intervention,markers pertaining torenal function,including blood creatinine,urea nitrogen,and24-hour urine protein levels,were notably reduced in the observation group compared to the control group ( P <0.05). Regarding the indices of immune functionality,there was a marked elevation in the levels of CD 3+ ,CD4 k+ ,and the CD4+/CD8+ratio in the observationgroup compared to thecontrol group.Conversely,the CD8+levels weresignificantly lowerin the observational group (P<0.05) .Interms of the overall frequency of adverse reactions,the observationgroup exhibitedaslightlyhigherrate (11%) compared to the control group (9 % ),though this differencedid not reach statistical significance (P>0.05) .ConclusionThe combination of tacrolimus and dapagliflozin has ahigh therapeutic efecton IgA nephropathyandcan promoterenal functionrecovery,improves immune function,and issafe.
【Key Words】Kidney function tests; Glomerulonephritis,IgA;Tacrolimus;Dapagliflozin;Immunologic function
IgA腎病的病理特征是IgA沉積于系膜區(qū),患者主要表現(xiàn)為腰酸、血尿等癥狀,部分患者還可能伴有多種并發(fā)癥,如高血壓、心血管疾病等1]。(剩余5460字)
-
-
- 山西醫(yī)藥雜志
- 2025年02期
- 益腎活血方治療Ⅲ期糖尿病腎病患...
- 基于陰道內(nèi)測(cè)壓法的產(chǎn)后壓力性尿...
- 艾司洛爾 + 體外膜肺氧合治療...
- 硼替佐米聯(lián)合沙利度胺地塞米松治...
- 他克莫司與達(dá)格列凈聯(lián)合用藥對(duì)I...
- 重癥監(jiān)護(hù)病房老年心力衰竭患者心...
- 左心系統(tǒng)造影聯(lián)合心臟磁共振成像...
- 基于受試者工作特征曲線分析經(jīng)顱...
- CT及磁共振成像診斷縱隔型肺癌...
- 卡瑞利珠單抗聯(lián)合多西他賽及奈達(dá)...
- 喜炎平注射液輔助治療小兒肺炎的...
- 卡瑞利珠單抗聯(lián)合介入治療對(duì)肝癌...
- 沙庫巴曲纈沙坦聯(lián)合阿托伐他汀治...
- 超聲引導(dǎo)下星狀神經(jīng)節(jié)阻滯在胃癌...
- 關(guān)節(jié)鏡輔助下改良三聯(lián)術(shù)治療復(fù)發(fā)...
- 引導(dǎo)式教育護(hù)理聯(lián)合認(rèn)知行為療法...
- 責(zé)任小組制的三級(jí)質(zhì)控護(hù)理在胰腺...
- 基于危重病護(hù)理評(píng)分法引導(dǎo)的干預(yù)...
- 《山西醫(yī)藥雜志》第六屆編委會(huì)青...